ERBB2 and cancer: It is important to consider the relevance of HER2 in determining the treatment approach. HER2+ diagnoses are correlated with detrimental clinical outcomes because HER2 increases proto-oncogenic signaling pathways, leading to uncontrolled cancer cell growth [2,4].